Back

Sarepta Therapeutics Stock Predictions

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.

Sell

SRPT
Sarepta Therapeutics

Last Price:

109.05

Seasonality Move:

19.2%

7 Day Trial

ALL ACCESS PASS

$ 7

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here

Sarepta Therapeutics Stock Forecast

Over the next 52 weeks, Sarepta Therapeutics has on average historically risen by 21.2% based on the past 27 years of stock performance.
Sarepta Therapeutics has risen higher in 16 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 59.26%
Is Sarepta Therapeutics Stock Undervalued?
The current Sarepta Therapeutics [SRPT] share price is $112.48. The Score for SRPT is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Sarepta Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Sarepta Therapeutics has on average historically risen by 21.2% based on the past 27 years of stock performance.

Sarepta Therapeutics Stock Rating

Sell

Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics overpriced?

Sarepta Therapeutics has risen higher in 16 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 59.26%

Sarepta Therapeutics Stock Price History

Is SRPT stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

sarepta.com

52-Week Data

52-Week High:

173.25

52-Week Low:

78.67

Prediction Charts

Market Cap:

10.74B

Price in USD:

112.48

Volume:

957.73K

Beta:

1.06

Technical Analysis

SMA50:

124.91

SMA100:

134.79

SMA200:

130.53

52-Wk Change:

41.18%

Stock Predictions

Is Sarepta Therapeutics stock public?
Yes, Sarepta Therapeutics is a publicly traded company.
What is the Sarepta Therapeutics stock quote today?
The Sarepta Therapeutics stock price is 112.48 USD today.
How to buy Sarepta Therapeutics stock online?
You can buy Sarepta Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Oct-25	132.10	131.14	133.36	130.93
Oct-28	131.37	130.26	132.80	129.26
Oct-29	130.07	130.19	131.17	129.26
Oct-30	129.32	127.70	130.86	127.40
Oct-31	127.32	126.00	128.19	125.92
Nov-1	125.91	123.29	126.51	122.68
Nov-4	123.30	123.07	124.03	121.01
Nov-5	123.00	125.01	125.25	121.18
Nov-6	126.50	127.97	128.32	122.45
Nov-7	132.40	120.42	133.00	117.52
Nov-8	120.50	121.61	121.96	116.32
Nov-11	121.88	117.79	122.63	117.53
Nov-12	118.00	114.29	118.73	114.12
Nov-13	113.63	112.48	116.30	111.53

Sarepta Therapeutics Earnings

Sarepta Therapeutics Earnings Report: Per Share Sarepta Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Sarepta Therapeutics Forecast Revenue Growth

Sarepta Therapeutics Stock Analysis: Historical quarterly revenues per share for Sarepta Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.55 per share.

* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.